Global Articaine Hydrochloride Market

Articaine Hydrochloride Market Size, Share, Growth Analysis, By Application(Infiltration, Nerve Block), By End User(Dental Clincs, Hospitals), By Region(North America, Latin America) - Industry Forecast 2024-2031

Report ID: SQMIG35I2330 | Region: Global | Published Date: April, 2024
Pages: 220 | Tables: 92 | Figures: 72

Articaine Hydrochloride Market News

  • In March 2023, With the use of extended-release technology, Septodont unveiled a unique articaine formulation that increased patient satisfaction and prolonged the duration of anesthesia. This development reinforces Septodont's position as a major player in the articaine hydrochloride segment and demonstrates the company's commitment to meeting unmet clinical demands and improving treatment outcomes in the worldwide dental anesthesia industry.
  • In September 2023, A new articaine hydrochloride solution with an inventive delivery mechanism has been introduced by Dentsply Sirona, which is expected to improve accuracy and patient comfort during dental treatments. The company's dedication to developing local anesthesia solutions and satisfying changing clinical needs in the international market is demonstrated by this progress.
  • In January 2022, Sanofi disclosed intentions to increase the range of products it offers by making strategic alliances and acquisitions. The objective of this effort is to enhance the company's standing in the dental anesthesia industry and leverage nascent prospects, propelling expansion and novelty in the worldwide articaine hydrochloride sector.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Articaine Hydrochloride Market size was valued at USD 1128.33 million in 2022 and is projected to grow from USD 1221.99 million in 2023 to USD 2135.33 million by 2031, growing at a CAGR of 8.3% in the forecast period (2024-2031).

The competitive landscape of the Articaine Hydrochloride Market is characterized by the presence of several international pharmaceutical companies striving to capture a significant market share. Key players such as Septodont, Dentsply Sirona, Pierrel Pharma, 3M Company, and Anhui BBCA Pharmaceutical Co., Ltd., are actively engaged in product development, strategic collaborations, and geographical expansion to strengthen their foothold in the market and meet the growing demand for articaine hydrochloride worldwide. '3M Company (US)', 'Siegfried Holding AG (Switzerland)', 'Novocol Healthcare Inc. (Canada)', 'Anhui BBCA Pharmaceutical Co., Ltd. (China)', 'Pierrel Group (Italy)', 'Johnson & Johnson (US)', 'Nortec Química S.A. (Brazil)', 'Sanofi (France)', 'Merck KGaA (Germany)', 'Septodont Healthcare India Pvt. Ltd. (India)', 'Transo-Pharm Handels GmbH (Germany)', 'Orgapharm (France)', 'Axyntis (France)', 'Benechim s.p.r.l (Belgium)', 'Green Stone Swiss Co., Ltd (Switzerland)', 'Moehs Iberica SL (Spain)'

Due to its quick onset and strong anaesthesia, dental professionals all around the world choose to use articaine hydrochloride. Its capacity to deliver efficient pain relief in a little amount of time improves patient happiness and comfort throughout a variety of dental procedures. This effectiveness results in better patient outcomes and drives the market for articaine hydrochloride to considerable expansion.

Growing Physician Preference: The use of articaine hydrochloride is growing due to the increase in dental procedures. Dentists use this anesthetic to reduce pain during dental treatments as it has deeper penetration into bone and soft tissues. With the advancement of pharmaceutical delivery technology, patients find Articaine Hydrochloride to be more effective and tolerable. The market is growing due to advances in treatment management and precision provided by computer-controlled local anesthetic delivery (CCLAD) devices. The benefits of articaine hydrochloride are being recognized by more doctors, which is increasing its popularity. IIt works better than standard anesthetics, according to dentists and oral physicians, which is great news for business.

Europe dominated the market in the past and is further anticipated to grow steadily as a result of rising dental treatment needs and attention. Another aspect propelling this market's expansion is Europe's increasing knowledge of preventative and remedial treatment. The new type of management system that would encourage dental professionals to run more efficient offices and free them up to concentrate on providing superior clinical treatment is the primary focus of the articaine hydrochloride market in Europe. The second-largest market share for articaine hydrochloride was held by North America. One of the reasons for the expansion of the articaine hydrochloride market in this area is the growing acceptance of the drug by dental practitioners.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Biosimulation Market
Buy Now GET FREE SAMPLE
Women’s Health Market
Buy Now GET FREE SAMPLE
Peptide Antibiotics Market
Buy Now GET FREE SAMPLE
Human Insulin Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Articaine Hydrochloride Market

Product ID: SQMIG35I2330

$5,300
BUY NOW GET FREE SAMPLE